Registry

TREATswitzerland is the patient registry for atopic dermatitis (neurodermatitis) in Switzerland. To date, there is a lack of accurate data on the medical care of patients with atopic dermatitis, the course of the disease and response to treatment, and the impact on quality of life. In an observational study of patients with moderate and severe atopic dermatitis, data will be collected and scientifically evaluated (observational cohort study).